1. Foy HM. Infections caused by Mycoplasma pneumoniae and
possible carrier state in different populations of patients. Clin
Infect Dis. 1993;17(Suppl 1):S37-S46.
2. Foy HM, Grayston JT, Kenny GE, Alexander ER, McMahan R. Epidemiology
of Mycoplasma pneumoniae infection in families. JAMA. 1966;197:137-144.
3. Fernald GW, Collier AM, Clyde WA. Respiratory infections
due to
Mycoplasma pneumoniae in infants and children.
Pediatrics. 1975;55:327-335.
[PubMed: 1143973]
4. Lind K, Benzon MW, Jensen JS, Clyde WA Jr. A seroepidemiological
study of
Mycoplasma pneumoniae infections in Denmark
over the 50-year period 1946-1995.
Eur J Epidemiol. 1997;13:581-586.
[PubMed: 9258572]
5. Dorigo-Zetsma JW, Wilbrink B, van der Nat H, Bartelds AI,
Heijnen ML, Dankert J. Results of molecular detection of
Mycoplasma
pneumoniae among patients with acute respiratory infection
and in their household contacts reveals children as human reservoirs.
J
Infect Dis. 2001;183:675-678.
[PubMed: 11170998]
6. Sande MA, Gadot F, Wenzel RP. Point source epidemic of
Mycoplasma
pneumoniae infection in a prosthodontics laboratory.
Am
Rev Respir Dis. 1975;112:213-217.
[PubMed: 1098534]
7. Rottem S. Invasion of mycoplasmas into and fusion with host
cells. In: Razin S, Herrmann R, eds. Molecular Biology and
Pathogenicity of Mycoplasmas. New York, NY: Kluwer Academic/Plenum
Publishers; 2002:391-402.
8. Tryon VV, Baseman JB. Pathogenic determinants and mechanisms.
In: Maniloff J, ed. Mycoplasmas: Molecular Biology and Pathogenesis.
Washington, DC: American Society for Microbiology; 1992:457-471.
9. Tanaka H, Koba H, Honma S, Sugaya F, Abe S. Relationships
between radiological pattern and cell-mediated immune response in
Mycoplasma pneumoniae pneumonia.
Eur
Respir J. 1996;9:669-672.
[PubMed: 8726929]
10. Tanaka H, Narita M, Teramoto S, et al. Role of interleukin-18
and T-helper type 1 cytokines in the development of
Mycoplasma
pneumoniae pneumonia in adults.
Chest. 2002;121:1493-1497.
[PubMed: 12006434]
11. Fonseca-Aten M, Okada PJ, Bowlware K, et al. Effect of clarithromycin
on cytokines and chemokines in children with an acute exacerbation
of recurrent wheezing: a double-blind, randomized, placebo-controlled
trial. Ann Allergy Asthma Immunol. 2006;97:467-463.
12. Narita M, Tanaka H, Togashi T, Abe S. Cytokines involved
in CNS manifestations caused by
Mycoplasma pneumoniae. Pediatr
Neurol. 2005;33:105-109.
[PubMed: 16087054]
13. Roifman CM, Rao CP, Lederman HM, Lavi S, Quinn P, Gelfand
EW. Increased susceptibility to
Mycoplasma infection
in patients with hypogammaglobulinemia.
Am J Med. 1986;80:590-594.
[PubMed: 3963038]
14. Becton DL, Friedman HS, Kurtzberg J, Chaffee S, Falletta
JM, Kinney TR. Severe
Mycoplasma pneumonia in three
sisters with sickle cell disease.
Pediatr Hematol Oncol. 1986;3:259-265.
[PubMed: 3153238]
15. Foy HM, Ochs H, Davis SD, Kenny GE, Luce RR.
Mycoplasma
pneumoniae infections in patients with immunodeficiency
syndromes: report of four cases.
J Infect Dis. 1973;127:388-393.
[PubMed: 4694545]
16. Shulman ST, Bartlett JG, Clyde WAJ, and Ayoub EM. The unusual
severity of mycoplasmal pneumonia in children with sickle cell disease.
N
Engl J Med. 1972;287:164-167.
[PubMed: 5033524]
17. Cherry JD. Anemia and mucocutaneous lesions due to Mycoplasma
pneumoniae infections. Clin Infect Dis. 1993;17:(Suppl
1):S47-S51.
18. el-Khatib M, Lerner AM. Myocarditis in
Mycoplasma
pneumoniae pneumonia. Occurrence with hemolytic anemia
and extraordinary titers of cold isohemagglutinins.
JAMA.
1975;231
:493-494.
[PubMed: 1172831]
19. Turtzo DF, Ghatak PK. Acute hemolytic anemia with
Mycoplasma
pneumoniae pneumonia.
JAMA. 1976;236:1140-1141.
[PubMed: 988873]
20. Ravin KA, Rappaport LD, Zuckerbraun NS, Wald, ER, Michaels
MM. Mycoplasma pneumoniae and atypical Stevens-Johnson
syndrome: a case series. Pediatrics. 2006;119:e1002-e1005.
21. Christie LJ, Honarmand S, Talkington DF, et al. Pediatric
encephalitis: what is the role of
Mycoplasma pneumoniae?
Pediatrics. 2007;120:305-313.
[PubMed: 17671056]
22. Leonardi S, Pavone P, Rotolo N, LaRosa M. Stroke in two
children with
Mycoplasma pneumoniae infection:
a causal or casual relationship?
Pediatr Infect Dis J. 2005;24:843-844.
[PubMed: 16148858]
23. Abele-Horn M, Franck W, Pusch U, Nitschko H, Roos R, Heesemann
J. Transverse myelitis associated with Mycoplasma pneumoniae infection. Clin
Infect Dis. 1998:26:909-912.
24. Koskiniemi, M. CNS manifestations associated with Mycoplasma
pneumoniae infections: summary of cases at the University
of Helsinki and review. Clin Infect Dis. 1993;17:(Suppl
1):S52-S57.
25. Thomas NH, Collins JE, Robb SA, Robinson RO.
Mycoplasma
pneumoniae infection and neurological disease.
Arch
Dis Child. 1993;69:573-576.
[PubMed: 8257178]
26. Lin WC, Lee PI, Lu CY, et al.
Mycoplasma pneumoniae encephalitis
in childhood.
J Microbiol Immunol Infect. 2002;35:173-178.
[PubMed: 12380790]
27. Stevens D, Swift PG, Johnston PG, Kearney PJ, Corner BD,
Burman D.
Mycoplasma pneumoniae infections in children.
Arch
Dis Child. 1978;53:38-42.
[PubMed: 626517]
28. Agustin ET, Gill V, Cunha BA.
Mycoplasma pneumoniae meningoencephalitis
complicated by diplopia.
Heart Lung. 1994;23:436-437.
[PubMed: 7989212]
29. Keegan BM, Lowry NJ, Yager JY.
Mycoplasma pneumoniae:
a cause of coma in the absence of meningoencephalitis.
Pediatr
Neurol. 1999;21:822-825.
[PubMed: 10593674]
30. Talkington DF. Mycoplasma and Ureaplasma in central nervous
system disorders. In: Scheld M, Whitley R, Marra C, eds. Infections
of the Central Nervous System. Philadelphia, PA: Lippincott,
Williams & Wilkins. 2008.
31. Taylor-Robinson D, Gumpel JM, Hill A, Swannell AJ. Isolation
of
Mycoplasma pneumoniae from the synovial fluid
of a hypogammaglobulinaemic patient in a survey of patients with inflammatory
polyarthritis.
Ann Rheum Dis. 1978;37:180-182.
[PubMed: 646469]
32. Taylor-Robinson D. Mycoplasmal arthritis in man.
Isr
J Med Sci. 1981;17:616-621.
[PubMed: 7287402]
33. Murray HW, Masur H, Sentenfit LBE. The protean manifestations
of
Mycoplasma pneumoniae infection in adults.
Am
J Med. 1975;58:229-242.
[PubMed: 163580]
34. Poggio TV, Orlando N, Galanternik L, Grinstein S. Microbiology
of acute arthropathies among children in Argentina:
Mycoplasma pneumoniae and
hominis and
Ureaplasma
urealyticum.
Pediatr Infect Dis J. 1998;17:304-308.
[PubMed: 9576384]
35. Andrews PA, Lloyd CM, Webb MC, Sacks SH. Acute interstitial
nephritis associated with
Mycoplasma pneumoniae infection.
Nephrol Dial
Transplant. 1994;9:564-566.
[PubMed: 8090341]
36. Schulman P, Piemonte TC, Singh B. Acute renal failure, hemolytic
anemia, and
Mycoplasma pneumoniae.
JAMA. 1980;244:1823-1824.
[PubMed: 7420684]
37. Said MH, Layani MP, Colon S, Faraj G, Glastre C, and Cochat
P.
Mycoplasma pneumoniae-associated nephritis in
children.
Pediatr Nephrol. 1999;13:39-44.
[PubMed: 10100287]
38. Farraj RS, McCully RB, Oh JK, Smith TF. Mycoplasma-associated
pericarditis.
Mayo Clin Proc. 1997;72:33-36.
[PubMed: 9005283]
39. Lind K. Manifestations and complications of
Mycoplasma
pneumoniae disease: a review.
Yale J Biol Med. 1983;56:461-475.
[PubMed: 6433567]
40. Sands MF Jr, Satz JE, Turner WE Jr., Soloff LA. Pericarditis
and perimyocarditis associated with active
Mycoplasma pneumoniae infection.
Ann
Int Med. 1977;86:544-549.
[PubMed: 851302]
41. Chen S, Tsai CC, Nouri S. Carditis associated with
Mycoplasma
pneumoniae infection.
Am J Dis Child. 1986;140:471-475.
[PubMed: 3083673]
42. Balaguer A, Boronat M, Carrascosa A. Successful treatment
of pericarditis associated with
Mycoplasma pneumoniae infection.
Pediatr Infect
Dis J. 1990;9:141-144.
[PubMed: 2107514]
43. Meseguer MA, Perez-Molina JA, Fernandez-Bustamante J, Gomez
R, Martos I, Quero MC.
Mycoplasma pneumoniae pericarditis
and cardiac tamponade in a ten-year-old girl.
Pediatr Infect
Dis J. 1996;15:829-831.
[PubMed: 8878230]
44. Szymanski M, Petric M, Saunders FE, Tellier R. Mycoplasma
pneumoniae pericarditis demonstrated by polymerase chain
reaction and electron microscopy. Clin Infect Dis. 2002;34:E16-E17.
45. Suzuyama T, Iwasaki H, Izumikawa K, Hara K. Other organs.
Yale
J Biol Med. 1983;56:487-490.
[PubMed: 6679144]
46Arav-Boger R., Assia A, Spirer Z, Bujanover Y, Reif S. Cholestatic
hepatitis as a main manifestation of Mycoplasma pneumoniae infection. J Pediatr
Gastroenterol Nutr. 1995;21:459-460.
47. Squadrini, F, Lami G, Pellegrino F, et al. Acute hepatitis
complicating
Mycoplasma pneumoniae infection.
J
Infect. 1988;16:201-202.
[PubMed: 3127476]
48. Denny FW, Clyde WA Jr., Glezen WP.
Mycoplasma pneumoniae disease:
clinical spectrum, pathophysiology, epidemiology, and control.
J Infect
Dis. 1971;123:74-92.
[PubMed: 5100980]
49. Waris ME, Toikka P, Saarinen T, et al. Diagnosis of
Mycoplasma
pneumoniae pneumonia in children.
J Clin Micro. 1998;36:3155-3159.
[PubMed: 9774556]
50. Dorigo-Zetsma JW, Zaat SAJ, Wertheim-van Dillen PME, et
al. Comparison of PCR, culture, and serological tests for diagnosis
of
Mycoplasma pneumoniae respiratory tract infection in
children.
J Clin Micro. 1999;37:14-17.
[PubMed: 9854056]
51. Ferwerda A, Moll HA, deGroot R. Respiratory tract infections
by
Mycoplasma pneumoniae in children: a review
of diagnostic and therapeutic measures.
Eur J Pediatr. 2001;160:483-491.
[PubMed: 11548186]
52. Smith CB, Friedewald WT, Chanock RM. Shedding of
Mycoplasma
pneumoniae after tetracycline and
erythromycin therapy.
N
Engl J Med. 1967;276:1172-1181.
[PubMed: 6023234]
53. Gavranich JB, Chang AB. Antibiotics for community acquired
lower respiratory tract infections (LRTI) secondary to Mycoplasma pneumoniae in
children. Cochrane Database Syst Rev. 2005:CD004875.
54. Block S, Hedrick J, Hammerschlag MR, Cassell GH, Craft JC.
Mycoplasma
pneumoniae and
Chlamydia pneumoniae in
pediatric community-acquired pneumonia: comparative efficacy and safety
of clarithromycin vs.
erythromycin ethylsuccinate.
Pediatr
Infect Dis. J. 1995;14:471-477.
[PubMed: 7667050]
55. Harris JA, Kolokathis A, Campbell M, Cassell GH, Hammerschlag
MR. Safety and efficacy of
azithromycin in the treatment of community-acquired
pneumonia in children.
Pediatr Infect Dis J. 1998;17:865-871.
[PubMed: 9802626]
56. Patel T, Pearl J, Williams J, et al. Efficacy and safety
of ten day
moxifloxacin 400 mg once daily in the treatment of patients
with community-acquired pneumonia.
Respir Med. 2000;94:97-105.
[PubMed: 10714413]
57. Finch R, Schurmann D, Collins O, et al. Randomized controlled
trial of sequential intravenous (i.v.) and oral
moxifloxacin compared
with sequential i.v. and oral co-amoxiclav with or without clarithromycin
in patients with community-acquired pneumonia requiring initial
parenteral treatment.
Antimicrob Agents Chemother. 2002;46:
1746-1754.
[PubMed: 12019085]
58. File TM Jr, Segreti J, Dunbar L, et al. A multicenter, randomized
study comparing the efficacy and safety of intravenous and/or
oral
levofloxacin versus ceftriaxone and/or cefuroxime
axetil in treatment of adults with community-acquired pneumonia.
Antimicrob
Agents Chemother. 1997; 41:1965-1972.
[PubMed: 9303395]
59. Niitu Y, Kubota H, Hasegawa S, Komatsu S, and Horikawa M.
Susceptibility of
Mycoplasma pneumoniae to antibiotics
in vitro.
Jpn J Microbiol. 1974;18:149-155.
[PubMed: 4473656]
60. Stopler T, Branski D. Resistance of
Mycoplasma pneumoniae to
macrolides, lincomycin and streptogramin B.
J Antimicrob
Chemother. 1986;18:359-364.
[PubMed: 3095300]
61. Matsuoka M, Narita M, Okazaki N, et al. Characterization
and molecular analysis of macrolide-resistant
Mycoplasma
pneumoniae clinical isolates obtained in Japan.
Antimicrob Agents
Chemother. 2004;48:4624-4630.
[PubMed: 15561835]
62. Suzuki S, Yamazaki T, Narita M, et al. Clinical evaluation
of macrolide-resistant
Mycoplasma pneumoniae. Antimicrob
Agents Chemother. 2006;50: 709-712.
[PubMed: 16436730]
63. Hyde TB, Gilbert M, S. Schwartz SB, et al.
Azithromycin
prophylaxis during a hospital outbreak of
Mycoplasma pneumoniae pneumonia.
J
Infect Dis. 2001;183:907-912.
[PubMed: 11237807]
64. Gray GC, McPhate DC, Leinonen M, et al. Weekly oral
azithromycin
as prophylaxis for agents causing acute respiratory disease.
Clin Infect
Dis. 1998;26:103-110.
[PubMed: 9455517]
65. Gucuyener K, Simsek F, Yilmaz O, and Serdaroglu A. Methyl-prednisolone
in neurologic complications of
Mycoplasma pneumonia. Indian
J Pediatr. 2000;67:467-469.
[PubMed: 10932970]
66. Carpenter TC. Corticosteroids in the treatment of striatal
encephalitis complicating Mycoplasma pneumoniae pneumonia:
possible benefit of intravenous immunoglobulin. Pediatr Infect
Dis J. 2002;20:534-545.
67. Taylor-Robinson D and McCormack WM. The genital mycoplasmas:
first of two parts.
NEJM. 1980;302:1003-1010.
[PubMed: 6988709]
68. Stacey CM, Munday PM, Taylor-Robinson D, et al. A longitudinal
study of pelvic inflammatory disease.
Br J Obstet Gynaecol. 1992;99:994-999.
[PubMed: 1477024]
69. Lamey JR, Eschenbach DA, Mitchell SH, et al. Isolation of
mycoplasmas and bacteria from the blood of postpartum women.
Am
J Obstet Gynecol. 1982;143:104-111.
[PubMed: 7081304]
70. Thomsen AC. Occurrence of mycoplasmas in urinary tracts
of patients with acute pyelonephritis.
J Clin Microbiol. 1978;8:84-88.
[PubMed: 670389]
71. Thomsen AC, Lindskoiv HO. Diagnosis of
Mycoplasma
hominis pyelonephritis by demonstration of antibodies in
urine.
J Clin Microbiol. 1979;9:681-687.
[PubMed: 500801]
72. Goldenbert RL, Andrews WW, Faye-Petersen OM, Goepfert AR,
Cliver SP, Hauth JC. The Alabama preterm birth study: intrauterine
infection and placental histologic findings in preterm births of
males and females less than 32 weeks. Am J Obstet Gynecol. 2006;195:1533-1537.
73. Ross JM, Furr PM, Taylor-Robinson D, Altman DG, Coid CR.
The effect of genital mycoplasmas on human fetal growth.
Br
J Obstet Gynaecol. 1981;88:749-755.
[PubMed: 7248235]
74. Berman SM, Harrison HR, Boyce WT, Haffner WJJ, Lewis M,
Arthur JB. Low birth weight, prematurity, and postpartum endometritis:
association with prenatal cervical
Mycoplasma hominis and
Chlamydia
trachomatis infections.
JAMA. 1987;257:1189-1194.
[PubMed: 3806917]
75. Wientzen RL. Genital mycoplasmas and the pediatrician.
Pediatr
Infect Dis J. 1990;9:232-235.
[PubMed: 2110650]
76. Waites KB, Rudd PT, Crouse DT, et al. Chronic
Ureaplasma
urealyticum and
Mycoplasma hominis infections
of central nervous system in preterm infants.
Lancet.
1988;1:17-21.
[PubMed: 2891889]
77. Waites KB, Duffy LB, Crouse DT, et al. Mycoplasma infections
of cerebrospinal fluid in newborn infants from a community hospital population.
Pediatr
Infect Dis J. 1990;9:241-245.
[PubMed: 2336309]
78. Valencia GB, Banzon F, Cummings M, McCormack WM, Glass L,
Hammerschlag MR.
Mycoplasma hominis and
Ureaplasma
urealyticum in neonates with suspected infection.
Pediatr Infect
Dis J. 1993;12:571-573.
[PubMed: 8345998]
79. McDonald JC, More DL.
Mycoplasma hominis meningitis
in a premature infant.
Pediatr Infect Dis J. 1988;7:795-798.
[PubMed: 3231501]
80. Gilbert GL, Law F, Macinnes SJ, Drew JH. Chronic Mycoplasma
hominis infection complicating severe intraventricular
hemorrhage, in a premature neonate. Pediatr Infect Dis J. 1988;11:817-818.
81. Wolthers KC, Kornelisse RF, Platenkamp GJJM, et al. A case
of
Mycoplasma hominis menigo-encephalitis in a
full-term infant: rapid recovery after start of treatment with
ciprofloxacin. Eur
J Pediatr. 2003;162:514-516.
[PubMed: 12740695]
82. Brooker RJ, Eason JD, Solimano A. Mycoplasma surgical wound
infection in a neonate.
Pediatr Infect Dis J. 1994;13:751-753.
[PubMed: 7970983]
83. Lequier L, Robinson J, Vaudry W. Sternotomy infection with
Mycoplasma
hominis in a neonate.
Pediatr Infect Dis J. 1995;14:1010-1011.
[PubMed: 8584343]
84. Glaser JB, Engelberg M, Hammerschlag M. Scalp abscess associated
with
Mycoplasma hominis infection complicating
intrapartum monitoring.
Pediatr Infect Dis. 1983;2:468-470.
[PubMed: 6657503]
85. Miller TC, Baman SI, Albers WH. Massive pericardial effusion
due to Mycoplasma hominis in a newborn. Am
J Dis Child. 1982:136:271-272.
86. Dan M, Tyrrell DLJ, Stemke GW, Robertson J. Mycoplasma
hominis septicemia in a burned infant. J Pediatr. 2981;99:743-744.
87. Luttrell LM, Kanj SS, Corey R, et al.
Mycoplasma
hominis septic arthritis: two case reports and review.
Clin
Infect Dis. 1994;19:1067-1070.
[PubMed: 7888535]
88. Glough W, Cassell GH, Duffy LB, Rinaldi RZ, et al. Septic
arthritis and bacteremia due to Mycoplasma resistant
to antimicrobial therapy in a patient with systemic lupus erythematosus. Clin
Infect Dis. 1992;15:402-407.
89. Mian AN, Farney AC, Mendley SR.
Mycoplasma hominis septic
arthritis in a pediatric renal transplant recipient: case report
and review of the literature.
Am J Transplant. 2005;5:183-188.
[PubMed: 15636628]
90. Dominguez SR, Littlehorn C, Nyquist A. Mycoplasma
hominis endocarditis in a child with a complex congenital
heart defect. Pediatr Infect Dis J. 2006;9:851-852.
91. Word BM, Baldridge A,
Mycoplasma hominis pneumonia
and pleural effusion in a postpartum adolescent.
Pediatr
Infect Dis J. 1990;9:295-296.
[PubMed: 2336318]
92. Donovan SM. Mycoplasma hominis meningitis complicating
head trauma: case report and review. Clin Infect Dis. 1997;24:272-273.
93. Douglas MW, Fisher DA, Lum GD, Roy J.
Mycoplasma
hominis infection of a subdural haematoma in the peripartum
period.
Pathol. 2003;35:452-453.
[PubMed: 14555394]
94. Mattila PS, Carlson P, Sivonen A, et al. Life-threatening
Mycoplasma
hominis mediastinitis.
Clin Infect Dis. 1999;29:1529-1537.
[PubMed: 10585808]
95. Taylor-Robinson D, Bebear C. Antibiotic susceptibilities
of mycoplasmas and treatment of mycoplasmal infections.
J
Antimicrob Chemother. 1997; 40:622-630.
[PubMed: 9421309]
96. Taylor-Robinson D.
Mycoplasma genitalium—an
update.
Int J STD AIDS. 2002;13:145-151. Haggerty
CL,Totten PA, Astete S, et al. The role of
Mycoplasma genitalium in
pelvic inflammatory disease.
Int J STE AIDS. 2006;17(suppl
1):9.
[PubMed: 11860689]
97. Yokoi S, Maeda S, Kubota Y, et al. The role of
Mycoplasma
genitalium and
Ureaplasma urealyticum biovar
2 in postgonococcal urethritis.
Clin Infect Dis. 2007;45:866-871.
[PubMed: 17806051]